Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$219.27 - $242.57 $57,010 - $63,068
-260 Reduced 53.17%
229 $55,000
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $97,252 - $111,296
489 New
489 $110,000
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $3.18 Million - $3.73 Million
-15,000 Closed
0 $0
Q2 2021

Jul 19, 2021

BUY
$233.58 - $259.14 $3.25 Million - $3.6 Million
13,910 Added 1276.15%
15,000 $3.66 Million
Q1 2021

May 11, 2021

SELL
$221.91 - $258.6 $221,910 - $258,600
-1,000 Reduced 47.85%
1,090 $271,000
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $11.4 Million - $13.6 Million
-52,910 Reduced 96.2%
2,090 $481,000
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $29.1 Million - $32.4 Million
-124,000 Reduced 69.27%
55,000 $14 Million
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $1.58 Million - $1.94 Million
-8,000 Reduced 4.28%
179,000 $42.2 Million
Q1 2020

May 12, 2020

SELL
$182.24 - $241.7 $26.2 Million - $34.8 Million
-143,877 Reduced 43.48%
187,000 $37.9 Million
Q4 2019

Feb 11, 2020

BUY
$189.21 - $243.2 $54.2 Million - $69.6 Million
286,385 Added 643.68%
330,877 $79.8 Million
Q3 2019

Nov 12, 2019

SELL
$174.11 - $208.62 $16.3 Million - $19.5 Million
-93,508 Reduced 67.76%
44,492 $8.61 Million
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $25 Million - $28.1 Million
138,000 New
138,000 $26.2 Million
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $3.13 Million - $3.65 Million
-17,547 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $3.11 Million - $3.51 Million
16,801 Added 2252.14%
17,547 $3.64 Million
Q2 2018

Aug 01, 2018

SELL
$166.05 - $186.51 $18.1 Million - $20.4 Million
-109,254 Reduced 99.32%
746 $138,000
Q1 2018

May 01, 2018

BUY
$169.43 - $198.0 $5.08 Million - $5.94 Million
30,000 Added 37.5%
110,000 $18.8 Million
Q4 2017

Feb 06, 2018

BUY
$168.79 - $188.59 $13.5 Million - $15.1 Million
80,000
80,000 $13.9 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mufg Securities Emea PLC Portfolio

Follow Mufg Securities Emea PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Securities Emea PLC, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Securities Emea PLC with notifications on news.